Total Payments
$1,382
2024 Payments
$251.92
Companies
15
Transactions
35
Medicare Patients
18,329
Medicare Billing
$14.9M
Payment Breakdown by Category
Food & Beverage$1,307 (94.6%)
Other$74.58 (5.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,307 | 34 | 94.6% |
| Entertainment | $74.58 | 1 | 5.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $317.45 | 9 | $0 (2021) |
| Bausch & Lomb Americas Inc. | $274.09 | 2 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $136.20 | 6 | $0 (2021) |
| Genentech USA, Inc. | $122.51 | 6 | $0 (2024) |
| ABBVIE INC. | $109.94 | 1 | $0 (2022) |
| Carl Zeiss Meditec, Inc. | $87.50 | 1 | $0 (2019) |
| Optos, Inc. | $74.58 | 1 | $0 (2017) |
| Amgen Inc. | $61.18 | 1 | $0 (2024) |
| Astellas Pharma US Inc | $52.38 | 2 | $0 (2023) |
| Harrow Eye, LLC | $35.36 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $251.92 | 4 | Bausch & Lomb Americas Inc. ($125.00) |
| 2023 | $125.08 | 5 | Astellas Pharma US Inc ($52.38) |
| 2022 | $353.45 | 7 | Bausch & Lomb Americas Inc. ($149.09) |
| 2021 | $46.98 | 2 | Allergan, Inc. ($28.82) |
| 2020 | $37.20 | 2 | Novartis Pharmaceuticals Corporation ($37.20) |
| 2019 | $201.18 | 6 | Carl Zeiss Meditec, Inc. ($87.50) |
| 2018 | $122.49 | 5 | Allergan Inc. ($51.93) |
| 2017 | $243.75 | 4 | Allergan Inc. ($157.07) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $61.18 | General |
| 12/18/2024 | Harrow Eye, LLC | IHEEZO (Drug) | Food and Beverage | In-kind items and services | $35.36 | General |
| Category: OPTOMETRY | ||||||
| 09/30/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $30.38 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/19/2024 | Bausch & Lomb Americas Inc. | enVista Aspire IOL (Device), enVista MX60 IOL, enVista MX60 IOL | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Ophthalmology | ||||||
| 12/11/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/31/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $21.02 | General |
| 10/16/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $32.09 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/13/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $31.36 | General |
| 03/29/2023 | Apellis Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $24.29 | General |
| 12/15/2022 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Ophthalmology | ||||||
| 11/28/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/01/2022 | Bausch & Lomb Americas Inc. | enVista MX60 IOL (Device) | Food and Beverage | In-kind items and services | $149.09 | General |
| Category: Ophthalmology | ||||||
| 09/20/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/01/2022 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $16.92 | General |
| 06/15/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Immunology and Ophthalmology | ||||||
| 01/19/2022 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $109.94 | General |
| Category: RETINA | ||||||
| 10/12/2021 | Allergan, Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $28.82 | General |
| Category: RETINA | ||||||
| 10/10/2021 | Novartis Pharmaceuticals Corporation | BEOVU (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/26/2020 | Novartis Pharmaceuticals Corporation | BEOVU (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/16/2020 | Novartis Pharmaceuticals Corporation | BEOVU (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/16/2019 | Allergan Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: RETINA | ||||||
| 11/04/2019 | Novartis Pharmaceuticals Corporation | BEOVU (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/30/2019 | Allergan Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $51.75 | General |
| Category: RETINA | ||||||
| 07/24/2019 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $18.49 | General |
| 07/15/2019 | Allergan Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: RETINA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 4,656 | 94,813 | $13.0M | $4.9M |
| 2022 | 22 | 4,875 | 29,161 | $9.6M | $4.3M |
| 2021 | 20 | 4,735 | 14,133 | $7.4M | $3.2M |
| 2020 | 22 | 4,063 | 12,938 | $5.7M | $2.5M |
Total Patients
18,329
Total Services
151,045
Medicare Billing
$14.9M
Procedure Codes
85
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 254 | 80,520 | $4.7M | $2.3M | 49.8% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 261 | 2,382 | $3.3M | $1.6M | 50.3% |
| 67028 | Injection of drug into eye | Office | 2023 | 702 | 3,110 | $2.8M | $291,075 | 10.4% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2023 | 34 | 784 | $240,125 | $123,766 | 51.5% |
| 92134 | Imaging of retina | Office | 2023 | 1,229 | 4,008 | $741,480 | $118,476 | 16.0% |
| J0179 | Injection, brolucizumab-dbll, 1 mg | Office | 2023 | 16 | 450 | $214,700 | $111,243 | 51.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 746 | 1,098 | $283,752 | $103,057 | 36.3% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 544 | 637 | $160,599 | $52,328 | 32.6% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 216 | 875 | $102,250 | $44,426 | 43.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 289 | 460 | $83,846 | $27,961 | 33.3% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 18 | 18 | $85,950 | $15,628 | 18.2% |
| 67108 | Repair of detached retina with drainage and removal of eye fluid between lens and retina | Facility | 2023 | 17 | 17 | $93,500 | $15,620 | 16.7% |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | Facility | 2023 | 19 | 20 | $111,600 | $10,364 | 9.3% |
| 67210 | Destruction of growth of retina using a laser | Office | 2023 | 18 | 20 | $36,000 | $7,666 | 21.3% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 72 | 72 | $19,545 | $7,162 | 36.6% |
| 67228 | Destruction of leaking blood vessels of retina using laser | Office | 2023 | 17 | 27 | $80,892 | $7,087 | 8.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $12,549 | $4,614 | 36.8% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 26 | 26 | $37,752 | $4,468 | 11.8% |
| 92250 | Photography of the retina | Office | 2023 | 83 | 84 | $10,164 | $2,218 | 21.8% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 29 | 29 | $8,620 | $2,195 | 25.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 28 | 138 | $1,416 | $111.22 | 7.9% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 384 | 4,052 | $4.3M | $2.9M | 67.9% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2022 | 117 | 13,080 | $566,800 | $390,325 | 68.9% |
| 67028 | Injection of drug into eye | Office | 2022 | 658 | 2,920 | $2.7M | $275,284 | 10.3% |
| J0179 | Injection, brolucizumab-dbll, 1 mg | Office | 2022 | 31 | 888 | $310,800 | $217,917 | 70.1% |
About Dr. Min-Kyu Han, M.D
Dr. Min-Kyu Han, M.D is a Ophthalmology healthcare provider based in Peoria, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1912901877.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Min-Kyu Han, M.D has received a total of $1,382 in payments from pharmaceutical and medical device companies, with $251.92 received in 2024. These payments were reported across 35 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,307).
As a Medicare-enrolled provider, Han has provided services to 18,329 Medicare beneficiaries, totaling 151,045 services with total Medicare billing of $14.9M. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Peoria, IL
- Active Since 06/09/2005
- Last Updated 10/20/2021
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1912901877
Products in Payments
- OZURDEX (Drug) $390.97
- enVista MX60 IOL (Device) $149.09
- enVista Aspire IOL (Device) $125.00
- IOLMaster 500 (Device) $87.50
- California (Device) $74.58
- BEOVU (Drug) $70.92
- VABYSMO (Drug) $58.89
- BROLUCIZUMAB (Drug) $46.79
- Vabysmo (Drug) $46.70
- IHEEZO (Drug) $35.36
- EYLEA HD (Biological) $32.09
- VYZULTA (Drug) $23.77
- Clareon (Device) $18.61
- XIIDRA (Drug) $12.10
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Peoria
Dr. Reuben Valenzuela, M.d, M.D
Ophthalmology — Payments: $508,013
Ophthalmology $508,013
Dr. Evan Lagouros, M.d, M.D
Ophthalmology — Payments: $21,719
Ophthalmology $21,719
Dr. Steven Lichtenstein, M.d, M.D
Ophthalmology — Payments: $9,629
Ophthalmology $9,629
Dr. Parminderpal Singh, Md, MD
Ophthalmology — Payments: $8,448
Ophthalmology $8,448
Colin Scott, Md, MD
Ophthalmology — Payments: $7,294
Ophthalmology $7,294
Dr. John Rhode, M.d, M.D
Ophthalmology — Payments: $5,065
Ophthalmology $5,065